Hashtag

Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum

Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum

MELBOURNE, Australia and SAN FRANCISCO, Jan. 3, 2023 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer will participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum (NIF). The forum is taking place Sunday, January 8, 2022, as part of the activities surrounding the annual J.P. Morgan Healthcare Conference.

At the conference, Dr. Stamler will be featured on a panel entitled, "New Approaches to Parkinson's and Movement Disorders." He will also present a company update and participate in investor and business development meetings.

The program for the 6th Annual NIF is designed to cover the latest developments in global bio-partnering and investment, with additional panels covering scientific advances in key therapeutic areas of neurodegenerative diseases and CNS more broadly, which includes neuropsychiatry, ophthalmology, neurotech and digital therapeutics.

About Alterity Therapeutics Limited

Alterity Therapeutics is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases. The Company's lead asset, ATH434, has the potential to treat various Parkinsonian disorders. Alterity also has a broad drug discovery platform generating patentable chemical compounds to intercede in disease processes. The Company is based in Melbourne, Australia, and San Francisco, California, USA. For further information please visit the Company's web site at www.alteritytherapeutics.com.

 Authorisation & Additional information

This announcement was authorized by David Stamler, CEO of Alterity Therapeutics Limited.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alterity-therapeutics-to-participate-in-the-sachs-associates-6th-annual-neuroscience-innovation-forum-301712033.html

Authors: PR Newswire

Read more https://www.prnasia.com/story/archive/3976287_CN76287_0

Health & Wellness

Understanding AED Defibrillator: Meaning, Uses, and Importance

Hashtag.net.au - avatar Hashtag.net.au

An AED defibrillator is a portable device used to treat people who are experiencing sudden cardiac arrest (SCA). The AED defibrillator meaning refers to a machine that can assess a person’s heart rh...

How to Maintain Your Oral Health During Stressful Times

Hashtag.net.au - avatar Hashtag.net.au

Life can be a bit like an Australian outback road—full of twists, turns, and the occasional bump. During these hectic, stressful times, it’s all too easy to let your oral health fall by the wayside...

The impact of visual art on mental health and productivity

Hashtag.net.au - avatar Hashtag.net.au

In a world where stress and anxiety often take center stage, the presence of visual art in our daily environments offers a quiet yet profound counterbalance. Posters and paintings are not just decor...